Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Using real-world data, cardiovascular safety was investigated in metformin users newly starting sodium glucose cotransporter 2 (SGLT2) inhibitors compared with other glucose-lowering drugs in Korea. METHODS: This was a retrospective observational study using the National Health Insurance...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ja Young, Ha, Kyoung Hwa, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369208/
https://www.ncbi.nlm.nih.gov/pubmed/33120439
http://dx.doi.org/10.4093/dmj.2020.0057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369208/
https://www.ncbi.nlm.nih.gov/pubmed/33120439
http://dx.doi.org/10.4093/dmj.2020.0057

Ejemplares similares